Network News

A new digital therapy concept provides people suffering from mental disorders with low-threshold and effective access to specialized psychosocial care. This can usefully complement existing services – as demonstrated by the PROVIDE-C study conducted by the Medical Faculty of Heidelberg University. The study was funded by the Federal Ministry of Education and Research (BMBF). Its […]

Combination approach could potentiate the success of immunotherapy MEDICAL NEED: Owing to advances in cancer research, mortality rates have decreased in recent years.1However, there are many patients who do not benefit from the plethora of available therapies becausetumors develop diverse immune escape mechanisms. Therefore, further development, investigation andimprovement of current and new therapies is imperative. […]

Heidelberg studies: online interventions might bridge healthcare gaps Digital self-help programs for adults with eating disorders may contribute to significantly reducing the symptoms in affected individuals. That is shown by two studies on binge eating and bulimia nervosa conducted by scientists at Heidelberg University. The Research Unit Clinical Psychology and Psychotherapy tested the potential of […]

Yesterday (October 16, 2024), NMI employee Dr. Nicole Anderle was awarded the Reinhold-und-Maria Teufel Foundation Prize for her doctorate on precision oncology. The prize is endowed with 5,000 euros and was presented to the scientist at the foundation’s headquarters in Tuttlingen. The challenges in cancer therapy are immense, especially the resistance to therapy in patients […]

The German Ethics Council is an expert body that advises parliament and government on social and, above all, medical and bioethical issues. Eva Winkler, Heisenberg Professor for Translational Medical Ethics at the Heidelberg Faculty of Medicine of Heidelberg University, has now been appointed to the Council. As Managing Director at the National Centre for Tumour […]

NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). “For too long, the Parkinson’s community has had […]

IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults.1 BOTOX® Cosmetic is the first and only product with four aesthetic indication areas: forehead lines, frown lines, […]

Scientists have discovered how the antiviral protein TRIM25 finds and binds viral RNA to activate an immune response Summary Every second of every day, our body is under attack. The invading agents are viruses, bacteria, parasites, toxins – living and non-living entities that might negatively impact our body’s functioning. What keeps us safe is a […]

Ruprecht Karls Prizes and Fritz Grunebaum Prize to be awarded on October 25 The Heidelberg University Foundation honors young academics with the Ruprecht Karls Prizes for their outstanding scientific publications. The awards go to five doctoral students from various disciplines. The Fritz Grunebaum Prize will also be awarded during the festive event in the auditorium […]